Cancer

Microfluidic Digital Nanobiosensors for Point-of-Care Detection of Analytes

Metabolically-fit Immunotherapies Portfolio

Metabolite Delivery for Modulating Metabolic Pathways of Cells

Neutrophil based CAR Therapies for Treatment

Central Carbon Metabolite Based Polymers for Tissue Regeneration

Central Carbon Metabolite Based Polymers for Immunotherapy

Hypoxia-Targeting Contrast Agent

Platform for Quantification of Transmembrane Protein Binding Kinetics

A Novel Immunotherapy for Treating Glioblastoma Multiforme

Autoantibodies for Identification of False Positives of Disease and Uses Thereof